Category: Psoriasis
Psoriasis market research reports by GlobalData
-
Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024
Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024 provides an overview of Generalized Pustular Psoriasis (GPP) Clinical trials scenario. This report provid ... Read More
-
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024 provides an overview of Plaque Psoriasis (Psoriasis Vulgaris) Clinical trials scenario. This report pro ... Read More
-
Digital Marketing Trends in Psoriasis - January 2024
Digital Marketing Trends in Psoriasis - January 2024 Summary AbbVie’s Skyrizi.com achieved the highest total traffic across branded PsO patient sites in the US, with almost three million visitors from January 2023 to December 2023. This was followed by Amgen’s Otezla.com (1.7 million visits). Overal ... Read More
-
Generalized Pustular Psoriasis (GPP) - Competitive Landscape
Generalized Pustular Psoriasis (GPP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in GPP therapeutics. More than 21,700 diagnosed prevalent cases of GPP are anticipated in 2023 in the 16 countries covered in GlobalData’s ... Read More
-
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Sta ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PsA therapeutics. There will be more than 6 million prevalent cases of PsA in 2023 in th ... Read More
-
Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type an ... Read More
-
Digital Marketing Trends in Psoriasis
Digital Marketing Trends in Psoriasis Summary AbbVie's Skyrizi.com achieved the highest total traffic across branded PsO patient sites in the US, with almost 7.2 million visitors between January 2022 - December 2022. This was followed by Novartis's Cosentyx.com (3.3 million visits) and AbbVie's Humi ... Read More
-
Psoriatic Arthritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Psoriatic Arthritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Psoriatic Arthritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, St ... Read More
Research Assistance
